United Kingdom

Back to map

Showing 1-10 of 36 grants

Title Institution Researcher Program Duration Total Award Amount
AI-Guided Development of a Vascularized Human Pancreas for In Vitro Type 1 Diabetes Modeling University of Hull Amin Ardestani Cures 01-April-2026 to 31-March-2027 $199.819,00
Novel biomarkers for identification of adult-onset Type 1 diabetes University of Exeter Angus Jones Cures 01-January-2026 to 31-December-2027 $898.312,00
Genetic risk modelling and implementation of EarLy Surveillance for Autoimmune Diabetes (ELSA) University of Birmingham Parth Narendran Cures 01-February-2026 to 31-January-2030 $653.050,94
Targeting alpha/beta hydrolase domain containing 11 (ABHD11) as a therapeutic target in type 1 diabetes Swansea University Nicholas Jones Cures 01-April-2026 to 31-March-2029 $621.914,00
Can dysregulated immunity to bacterial lipopolysaccharide aid in identifying those at risk of developing Type 1 diabetes? University of Birmingham James Pearson Cures 01-April-2026 to 31-March-2029 $667.691,00
Unraveling the Mechanisms of HLA-DQ8 Graft Acceptance: Insights from the Largest Single Cohort of Islet Transplant Recipients in the Edmonton Program The University of Edinburgh Shareen Forbes Cures 01-October-2025 to 30-September-2027 $749.938,79
Investigating and Optimising the translational potential of NAMPT inhibition in type 1 diabetes King's College London Paul Caton Cures 01-November-2025 to 31-October-2028 $859.147,00
Defining metabolic dysfunction and use of adjunct therapies in type 1 diabetes, using real-world data Imperial College London Shivani Misra Improving Lives 01-October-2025 to 30-September-2027 $701.005,42
Understanding the impact of endogenous insulin secretion on clinical outcomes in type 1 diabetes and the optimal approach to C-peptide measurement for outcome prediction University of Exeter Angus Jones Cures 01-June-2025 to 31-May-2027 $581.477,00
Unlocking the translational potential of extreme forms of autoimmune diabetes by uncovering heterogeneous mechanisms of beta-cell autoimmunity University of Exeter Matthew Johnson Cures 01-April-2024 to 31-March-2029 $335.110,00